Magellan Launches Total Drug SolutionsSM Offering Complete Drug Management

Magellan Pharmacy Solutions, a subsidiary of Magellan Health Services Inc. (NASDAQ: MGLN), announced today the launch of Total Drug Solutions SM, a revolutionary integrated approach to managing all drugs – oral, injectable and infusible – to improve the quality and safety of care while lowering costs for consumers and health plans.

“Historically, patients have received standard medications and specialty drugs in a disconnected and uncoordinated fashion. This lack of integration presents safety risks, decreases therapeutic effectiveness and unnecessarily increases costs,” said Tina Blasi, president of Magellan Pharmacy Solutions.

“Payers have managed traditional pharmaceutical costs to a flat trend. However, specialty drug spending has increased dramatically . With recent advances in pharmaceutical technology, patients and payers need better support to coordinate treatment, manage costs and ensure patients achieve the best outcomes.

Total Drug Solutions combines our strengths in both specialty and medical drug management with our experience in traditional pharmacy benefit solutions to provide a patient-centric, 360-degree approach to drug management. Our philosophy is to help patients receive the right drug in the right amount at the right place.”

Magellan has launched a new website, www.TotalDrugSolutions.com, where health plans, employers and government agencies can learn more about the Total Drug Solutions suite of services. Evidence-based drug utilization tools ensure that coverage decisions are consistently applied across both medical and pharmacy benefits, reducing the variability of care. Magellan has enhanced its proprietary web-based utilization management system to empower providers with evidence-based information and decision support for all drugs.

“Our customers recognize that the true value comes in incorporating our specialty and medical pharmacy experience into these integrated, comprehensive services,” said Blasi.

“We combine this ‘total drug’ approach with a deep understanding of the most dynamic, and most difficult to manage, components of drug benefit management, such as utilization management in the physician practice and site-of-service management. This unrivaled breadth of experience and expertise will allow us to customize solutions to meet the changing needs of our customers.”

If you liked this article you might like

Healthcare Stocks Mixed Following Senate Vote to Proceed on Healthcare Bill

Magellan Shares Up Strong After Shelling Out $400M to Buy Senior Whole Health

UnitedHealth to Test Durability of 2017's Strong Start

Today's Strong And Under The Radar Stock Is Magellan Health (MGLN)

Insider Trading Alert - MGLN, AZZ And DY Traded By Insiders